Related Experiment Video
Updated: Jun 15, 2026

Prehospital Thrombolysis: A Manual from Berlin
Published on: November 26, 2013
Fibrinolysis versus primary percutaneous intervention in ST-elevation myocardial infarction with long interhospital
Abhimanyu Beri1, Mary Printz, Ansar Hassan
1East Carolina University/Pitt County Memorial Hospital, Greenville, North Carolina, USA. abhiberi@gmail.com
Insights
For ST-elevation myocardial infarction (STEMI) patients requiring long-distance transfer, pre-transfer fibrinolysis did not delay treatment or worsen outcomes compared to direct transfer for primary percutaneous coronary intervention (pPCI). This approach is safe and effective in longer transfer scenarios.
Area of Science:
- Cardiology
- Emergency Medicine
- Interventional Cardiology
Background:
- Current guidelines advocate for rapid reperfusion therapy in ST-elevation myocardial infarction (STEMI).
- Primary percutaneous coronary intervention (pPCI) is preferred over fibrinolysis for STEMI, especially with short transfer distances.
- Outcomes for STEMI patients with longer transfer times receiving pre-transfer fibrinolysis are not well-established.
Purpose of the Study:
- To evaluate the impact of administering fibrinolysis before interhospital transfer for STEMI on transfer times and patient outcomes.
- To compare outcomes between STEMI patients receiving pre-transfer fibrinolysis versus direct transfer for pPCI in longer transfer scenarios.
Main Methods:
- A retrospective analysis of 259 STEMI patients transferred to a pPCI-capable center.
- Patients were divided into two groups: direct pPCI transfer (43 patients) and pre-transfer fibrinolysis (216 patients).
- Primary endpoint was door-to-door time; secondary endpoints included stroke, death, bleeding, and combined adverse events.
Main Results:
- Door-to-door times were similar between the pPCI and fibrinolysis groups (135 vs. 128 minutes, P=0.71).
- In-hospital mortality was significantly lower in the fibrinolysis group (1.9%) compared to the pPCI group (9.3%, P=0.03).
- Combined incidence of stroke, significant bleeding, and death was not significantly different between groups (14% vs. 7%, P=0.13).
Conclusions:
- Pre-transfer fibrinolysis for STEMI patients in longer transfer settings does not significantly delay transfer times.
- This strategy does not appear to lead to worse clinical outcomes compared to direct transfer for pPCI.
- Fibrinolysis followed by transfer may be a viable option for STEMI patients when pPCI is not immediately available due to distance.
Background:
Current guidelines recommend rapid initiation of reperfusion therapy for ST-elevation myocardial infarction (STEMI), with short-distance transfer for primary percutaneous coronary intervention (pPCI) preferred over fibrinolysis in non-pPCI-capable hospitals. Comparative outcomes in patients with longer transfer times are unclear.
Hypothesis:
We designed this study to assess whether administering fibrinolytics prior to initiating longer-distance interhospital transfer in patients with STEMI leads to a delay in transfer or worse outcomes compared with transfer for pPCI.
Methods:
We analyzed 259 STEMI patients transferred to a receiving pPCI-capable center in eastern North Carolina. The patients were divided into 2 groups, with 43 (16.6%) transferred for pPCI and the remaining 216 (83.4%) transferred following fibrinolysis. The primary endpoint was door-to-door time. We also compared stroke, death, significant bleeding, and combined outcomes between the 2 groups.
Results:
The median door-to-door time was similar for pPCI and fibrinolysis patients (135 vs 128 minutes; P = 0.71). Median door-to-balloon time among pPCI patients was 182 minutes from the point of arrival at the referral hospital and 49 minutes from arrival at the receiving pPCI center. Median door-to-needle time in the fibrinolysis patients was 30 minutes, with rescue PCI eventually performed in 81 (37.5%) patients. In-hospital mortality was higher in patients with pPCI (9.3%) compared with fibrinolysis patients (1.9%; P = 0.03). Combined incidence of stroke, significant bleeding, and death was 14% in pPCI patients compared with 7% in fibrinolysis patients (P = 0.13).
Conclusions:
In settings with longer transfer distances, administering fibrinolytics prior to transfer to a pPCI-capable center did not cause any significant delay in transfer or worse outcomes.
Related Concept Videos
Acute Coronary Syndrome I: Introduction
Acute Coronary Syndrome IV: Interprofessional Care
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Peripheral Artery Disease III: Interprofessional Care
Venous Thrombosis III: Interprofessional Care
Clot Retraction and Fibrinolysis
